Navigation Links
Leading lampreys to slaughter: Pheromone for scourge of Great Lakes identified

"The GLFC has the goal of controlling lamprey with a new and better technique by 2010. This could be it," said Peter Sorensen, a professor of fisheries, wildlife and conservation biology who led the study with chemistry professor Thomas Hoye. "Also, lamprey are important to native peoples on the West Coast, who value it for food. This pheromone could help restore lamprey runs by attracting lamprey to suitable spawning beds."

When they stop feeding, lamprey seek out streams for spawning by following the pheromone trails. After arriving at the spawning grounds, a sex pheromone -- which was identified by Weiming Li, an earlier doctoral student of Sorensen -- attracts the females to males. After spawning, which takes a few weeks, the adults die.

It has taken Sorensen and his colleagues about 15 years to find, isolate and purify the pheromone so that Hoye and his colleagues could identify and synthesize it. The key component is a steroid with potency so great that lampreys would smell a single gram dissolved in 10 billion liters of water, enough to fill 5,000 Olympic-sized swimming pools. This level of potency tops that of all other fish attractants, including those of salmon.

To find the pheromone, the researchers extracted 8,000 liters of water from tanks holding 35,000 larvae. The yield was less than a milligram, or 35 millionths of an ounce. Much of the work in isolating and purifying the pheromone was performed by Sorensen's graduate student Jared Fine, while Vadims Dvornikovs, Christopher Jeffrey and Feng Shao in Hoye's lab were integral to synthesizing the key component, called PADS. The chemical structure of PADS is very similar to that of squalamine, a compound made by the "dogfish" shark. Squalamine has been reported to work against cancer by inhibiting the growth of blood vessels that feed tumors but not other blood vessels. The other two components of the pheromone are a second steroid and an already known, lamprey-specific b
'"/>

Source:University of Minnesota


Page: 1 2 3

Related biology news :

1. Leading scientists rank endangered dolphins, porpoises most in need of immediate action
2. Leading reason for corneal transplants comes into focus
3. Pheromone from mothers milk may rapidly promote learning in newborn mammals
4. Great White shark evolution debate involves WSU Lake Campus geology professor
5. Aggressive aquatic species invading Great Lakes
6. Low oxygen likely made Great Dying worse, greatly delayed recovery
7. HIV Therapy Greatly Extends Life of Key T Cells, Scientists Find
8. Great (taste) expectations: Study shows brain anticipates taste, shifts gears
9. UNH researcher restoring oyster reefs to Great Bay
10. CSIRO imagery shows Outer Great Barrier Reef at risk from river plumes
11. National Academies advisory: Invasive aquatic species in the Great Lakes

Post Your Comments:
(Date:11/30/2009)...y of Pittsburgh team overcame a major hurdle plagu... that could lead to more efficient catalysts used ...xic. The researchers reported Nov. 29 in Nature M...ure stability in metallic nanoparticles, the vaunt...bility to extreme heat. , Gtz Veser, an associat...
(Date:11/30/2009)...ournal of Experimental Biology are pleased to ann...e la Recherche Scientifique (CNRS) in the Universi...ear,s JEB Outstanding Paper Prize. ,The prize is...ent and is intended to encourage young scientists,...and adds that ,we truly appreciate when authors su...
(Date:11/30/2009)...er early bird registration rates and register onli...010 at http://www.iofwco-ecceo10.org/ , WHAT:...ational Osteoporosis Foundation (IOF) and the Euro...Osteoporosis and Osteoarthritis (ESCEO). More than...cted to attend. The exciting scientific programme ...
Breaking Biology News(10 mins):First metallic nanoparticles resistant to extreme heat 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4Perrigo Company To Present at the Sidoti Emerging Growth Conference 6399 1How to execute dietary management in eating disorder patients 61699 1How to execute dietary management in eating disorder patients 61699 2TGen Drug Development establishes European footprint 10804 1TGen Drug Development establishes European footprint 10804 2
... identified a gene ?and the molecular function of ...ue to further understanding obesity and may point ..., The scientists found that the human protein know... activity may be an important pharmaceutical targe...conditions that range from obesity to the loss of ...
...a risk for gastrointestinal illness, most visitors...d prevent infection. In addition, some engage in b...on according to several studies being presented th...g Infectious Diseases. , Researchers from the CDC... of an outbreak of , E. coli O157:H7 associated ...
...ail of scents when they are attacked by certain pe...otton leaf worm. , Parasitic wasps use these plant...eir eggs on it, so that their offspring can feed o...es and the plant is relieved from its attacker. In... activated to attract the parasitic wasps. This ge...
Other Biology News:Rutgers researchers find fat gene 2Common practices at petting zoos put visitors at risk 2New possibilities to fight pests with biological means 2
(Date:11/30/2009)...30 Acuo Technologies, developers o...re, data migration tools and services, today annou... for a new Vendor Neutral Archive (VNA), providing... network of hospitals, clinics and affiliates. ,...hnologies DICOM Services Grid(TM) Software. The A...
(Date:11/30/2009)... Novavax, Inc. (Nasdaq: ... today that the company will be presenting at the ...r 2, 2009 at 12:30 pm local time at The New York P... of the company,s business strategy, research and ...ink to the live audio only presentation can be acc...
(Date:11/30/2009)...30 Biopharmaceutical company Kiadi...ave been enrolled in its,multinational registratio...ned to show reduction in transplant related mortal...tem cell transplantation with a mismatched,(haplo-... for an allogeneic,stem cell transplantation but w...
(Date:11/30/2009)...nd LOS ANGELES, Nov. 30 /PRNewswire-Asia-FirstCall...etin Board: CYXN; ,China Yongxin,Pharmaceuticals, ...utor and,retailer of pharmaceuticals in Northeaste...tion for distribution of medicines on the Essentia...ently formalized the nation,s Essential Drug,List ...
Breaking Biology Technology:Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 2China Yongxin Pharmaceuticals Inc. to Distribute Medicines on the Essential Drug List 3
...AIN VIEW, Calif., March 12 Alexza,Pharmaceuticals...ll release,results for its fiscal year ended Decem...the close of the U.S. financial markets. The Compa...s the financial results and other,clinical develop...ay. A,replay of the call will be available for two...
...ded Agreement Accelerates Expected Timing of Final...le Powering of Interim and Final Results-, -Dendre...2008 at 11:00 AM ...daq: DNDN ) today announced that the U.S. Food an...ed Special Protocol Assessment (SPA) for the,Phase...
...nds PDE10 Collaboration with Amgen- -Com...ONTVALE, N.J., March 12 Memory,Pharmaceuticals Co...ealigned,its operations, reallocated its resources...its PDE10 collaboration with Amgen. The Company wi...o partnered programs, its,nicotinic alpha-7 recept...
Other Biology Technology:Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008 2Alexza to Announce 2007 Financial Results and Update Its Clinical Pipeline on Monday, March 17, 2008 3FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE 2FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE 3FDA Agrees to Amend Dendreon's Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE 4Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 2Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 3Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 4Memory Pharmaceuticals Refocuses to Advance Development and Clinical Programs 5
Fingerprinting II Informatix, optional matrix types module from Bio-Rad
... Lines ,High Quality, Functionally-Validated, Ion ...for having a critical role in nerve and muscle fun..., CNS and the heart. Drugs that modulate ion chann...uch as neuropathic pain, cardiac arrhythmia, hyper...
...are derived from frozen embedded tissue blocks, wh...edures to ensure the highest quality. Tissues of e...tioned at a thickness of 7 microns and mounted on ...ter) in comparison to core sections made using Tis...
...ations or for use in an automated line. The StatMa...fold provides greater ease, speed, convenience, an...StatMatic II can be connected to a range of bottle...ne-handed operation -- in a matter of seconds.,T...
Biology Products: